| Filed On | Filing |
|---|---|
| 04 Jan 2024 |
Form 3: Maltz Elliot, Chief Financial Officer
No securities owned |
| 13 Dec 2023 |
Form 3: Wood Todd Michael, President of U.S. Operations
No securities owned |
| 08 Nov 2023 |
Form 3: Pax Margaret, Director
No securities owned |
| 11 Aug 2023 |
Form 3: Caligan Partners Lp, 10% owner and 1 other
Holds 478,777 shares of Common Stock, par value $0.01 per share ("Common Stock") |
| 03 Aug 2023 |
Form 3: DeMont Ross D, Director
No securities owned |
| 19 May 2023 |
Form 3: Velan Capital Investment Management Lp, 10% owner and 5 others
Holds 1,659,654 shares of Common Stock |
| 19 May 2023 |
Form 3: Werner Jason M., Director
No securities owned |
| 28 Mar 2023 |
Form 3: Kaseta Michael, Director
No securities owned |
| 28 Mar 2023 |
Form 3: Morgan Adam, Director
Holds 257,753 shares of Common Stock |
| 01 Mar 2023 |
Form 3: Sawhney Roger, Director
No securities owned |
| 10 Jan 2023 |
Form 3: Skibsted Russell, Chief Financial Officer & SVP
No securities owned |
| 10 Feb 2022 |
Form 3: Morgan Stanley, 10% owner
Holds 807,551 shares of Common Stock |
| 02 Dec 2021 |
Form 3: Parsons Erin, Director
No securities owned |
| 30 Apr 2021 |
Form 3: Ocumension Therapeutics, 10% owner
Holds 1,144,945 shares of Common Stock, $.01 par value |
| 22 Jul 2019 |
Form 3: Snisarenko John, Director
No securities owned |
| 12 Apr 2019 |
Form 3: Kaba Samer, Chief Medical Officer
Holds 71,000 shares of Common Stock |
| 11 Jan 2019 |
Form 3: Jones John Philip, Chief Financial Officer
Holds 32,018 shares of Common Stock |
| 21 Jun 2018 |
Form 3: Szela Mary T, Director
No securities owned |
| 09 Feb 2018 |
Form 3: Armistice CAPITAL, Llc, 10% owner and 2 others
Holds 6,916,000 shares of Common Stock, $.01 par value |
| 09 Oct 2015 |
Form 3: Flynn James E, 10% owner and 7 others
Holds 4,041,997 shares of Common Stock |
Loading...
